Arrowhead Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	1,091	829.45	3.55	240.74	243.23	138.29
Revenue Growth (YoY)	43539.20%	23258.15%	-98.52%	-1.03%	75.89%	57.16%
Gross Profit	1,091	829.45	3.55	240.74	243.23	138.29
Selling, General & Admin	143.05	123.94	98.76	92.55	124.43	80.98
Research & Development	647.36	607.16	505.87	353.19	297.31	206.34
Total Operating Expenses	790.41	731.1	604.63	445.74	421.74	287.32
Operating Income	300.57	98.35	-601.08	-205	-178.51	-149.04
Interest Income	39.38	37.29	22.72	15.3	5.03	6.12
Interest Expense	-90.22	-89.36	-32.35	-18.33	-	-
Other Non-Operating Income (Expense)	5.2	5.26	-1.75	1.54	0.77	2.07
Total Non-Operating Income (Expense)	-48.43	-46.81	-11.38	-1.49	5.8	8.19
Pretax Income	254.92	51.53	-612.46	-206.49	-172.71	-140.85
Provision for Income Taxes	21.35	21.42	-2.77	2.78	3.79	0
Net Income	202.27	-1.63	-599.49	-205.28	-176.06	-140.85
Minority Interest in Earnings	31.31	31.75	-10.2	-4	-0.43	-
Net Income to Common	202.27	-1.63	-599.49	-205.28	-176.06	-140.85
Shares Outstanding (Basic)	137	134	120	107	105	104
Shares Outstanding (Diluted)	137	134	120	107	105	104
Shares Change (YoY)	10.57%	11.67%	12.21%	1.26%	1.62%	3.00%
EPS (Basic)	1.56	-0.01	-5.00	-1.92	-1.67	-1.36
EPS (Diluted)	1.53	-0.01	-5.00	-1.92	-1.67	-1.36
Shares Outstanding	137.39	135.7	124.38	107.31	105.96	104.33
Free Cash Flow	322.01	156.89	-604.32	-330.63	-188.91	147.75
Free Cash Flow Growth	105.25%	-	-	-	-	-
Free Cash Flow Per Share	2.35	1.17	-5.05	-3.10	-1.79	1.42
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	27.55%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Profit Margin	21.41%	3.63%	-17169.60%	-86.93%	-72.56%	-101.85%
FCF Margin	29.52%	18.91%	-17018.30%	-137.34%	-77.67%	106.84%
EBITDA	325.23	122.27	-582.49	-192.51	-168.09	-140.77
EBITDA Margin	29.81%	14.74%	-16403.40%	-79.97%	-69.11%	-101.79%
EBIT	300.57	98.35	-601.08	-205	-178.51	-149.04
EBIT Margin	27.55%	11.86%	-16927.10%	-85.16%	-73.39%	-107.77%
Effective Tax Rate	8.37%	41.56%	0.45%	-1.35%	-2.19%	-0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q